NCT00456885View on ClinicalTrials.gov

The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
ObesityImpaired Glucose Tolerance
Interventions
DRUG

exenatide

5 microgram twice a day for two week and then 10 mcg for remaining 15 weeks

DRUG

Placebo

Twice daily injection of placebo

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER